Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) have received a consensus recommendation of “Hold” from the fourteen brokerages that are currently covering the company, Marketbeat reports. Ten analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $23.58.
A number of research firms have recently issued reports on XRAY. Evercore ISI reiterated an “in-line” rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Morgan Stanley reduced their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Barrington Research lowered their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a report on Friday, February 28th. Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th.
View Our Latest Stock Report on XRAY
Insider Activity at DENTSPLY SIRONA
Institutional Investors Weigh In On DENTSPLY SIRONA
A number of institutional investors have recently made changes to their positions in the company. Nordea Investment Management AB boosted its holdings in DENTSPLY SIRONA by 245.0% in the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock worth $4,754,000 after purchasing an additional 178,639 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after buying an additional 1,244,326 shares during the period. Barclays PLC grew its position in shares of DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock valued at $8,301,000 after buying an additional 54,920 shares during the last quarter. Canvas Wealth Advisors LLC raised its stake in DENTSPLY SIRONA by 126.5% during the fourth quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier’s stock worth $6,245,000 after acquiring an additional 182,234 shares during the period. Finally, Quantinno Capital Management LP lifted its holdings in DENTSPLY SIRONA by 276.5% in the third quarter. Quantinno Capital Management LP now owns 116,808 shares of the medical instruments supplier’s stock worth $3,161,000 after acquiring an additional 85,787 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.
DENTSPLY SIRONA Stock Up 3.6 %
Shares of NASDAQ XRAY opened at $16.15 on Friday. The stock has a fifty day moving average price of $18.71 and a 200 day moving average price of $21.32. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 12-month low of $15.47 and a 12-month high of $34.28. The company has a market cap of $3.21 billion, a P/E ratio of -7.80, a P/E/G ratio of 1.80 and a beta of 0.96.
DENTSPLY SIRONA Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 3.96%. DENTSPLY SIRONA’s payout ratio is -14.07%.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More
- Five stocks we like better than DENTSPLY SIRONA
- How to Invest in Biotech Stocks
- Corporate Crawl: Where Business Trips Turn Into Party Nights?
- The Role Economic Reports Play in a Successful Investment Strategy
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Stock Dividend Cuts Happen Are You Ready?
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.